Emil Najjar

ST2 in heart failure with preserved and reduced ejection fraction

Emil Najjar, Ulrika Ljung Faxén, Camilla Hage et al. · Scandinavian Cardiovascular Journal · 2019 · 57 citations · Full text

Medicine, Cardiology, Cardio-oncology +13

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Validation of Non-Invasive Ramp Testing for HeartMate 3

Emil Najjar, Tonje Thorvaldsen, Magnus Dalén et al. · ESC Heart Failure · 2020 · 19 citations · Full text

Medicine, Cardiology, Surgery +15

The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios

Kevin M. Veen, Christoffer Stark, Luca Botta et al. · European Journal of Cardio-Thoracic Surgery · 2025 · 16 citations · Full text

Medicine, Cardiology, Surgery +13

Haemodynamic Effects of Levosimendan in Advanced but Stable Chronic Heart Failure

Emil Najjar, Marcus Stålhberg, Camilla Hage et al. · ESC Heart Failure · 2018 · 15 citations · Full text

Medicine, Cardiology, Pharmacology +16